SCHEMBL2635488

SCHEMBL2635488

CC(C)(Br)c1ccc(=O)[nH]c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.48
IDH1 O75874 3/20 0.34
TRPV6 Q9H1D0 1/20 0.34
TSHR P16473 1/20 0.33
CASP1 P29466 1/20 0.33
CASP7 P55210 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
HSD17B10 Q99714 1/20 0.33
AOC3 Q16853 1/20 0.32
DGAT1 O75907 1/20 0.32
SOAT1 P35610 1/20 0.32
KCNH2 Q12809 1/20 0.32
FKBP5 Q13451 1/20 0.31
RORC P51449 1/20 0.31
GAA P10253 1/20 0.31
POLB P06746 1/20 0.30
KDM4E B2RXH2 1/20 0.30
MAPT P10636 1/20 0.30
THRB P10828 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9605457 0.84 ALDH1A1 (0.44) ALDH1A1IDH1TSHRCASP1CASP7
SCHEMBL24880084 0.80 ALDH1A1 (0.41) ALDH1A1IDH1TSHRCASP1CASP7
SCHEMBL20206735 0.77 ALDH1A1 (0.39) ALDH1A1IDH1TRPV6TSHRCASP1
SCHEMBL21324857 0.77 NPC1 (0.43) ALDH1A1IDH1TRPV6TSHRCASP1
SCHEMBL31292260 0.75 SGK1 (0.38) ALDH1A1SMN1; SMN2RORCGAAPOLB
SCHEMBL609810 0.74 DGAT1 (0.45) ALDH1A1HSD17B10DGAT1SOAT1KCNH2
SCHEMBL19646432 0.74 ALDH1A1 (0.36) ALDH1A1IDH1TRPV6SMN1; SMN2RORC
SCHEMBL31292404 0.71 CNR1 (0.43) ALDH1A1RORCGAAPOLB
SCHEMBL24866060 0.71 CNR2 (0.40) ALDH1A1
SCHEMBL1415743 0.71 TSHR (0.44) ALDH1A1TSHRHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023146512-A1 COMPOUNDS AND METHODS OF USE THEREOF VIVACE THERAPEUTICS, INC. (US) 2023-08-03 WO disclosed
EP-2569313-A1 COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE Vertex Pharmaceuticals Incorporated (US) 2013-03-20 EP disclosed
WO-2011143426-A1 COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-11-17 WO disclosed